Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
APPCB issues show-cause notices to 95 industries in Parawada over 'untreated waste'
Andhra Pradesh Pollution Control Board (APPCB) has issued show-cause notices to 95 industries in the Parawada JN Pharma City area in Anakapalli district, following complaints on social media about black-coloured water flowing through drains and…
Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a report issued on Saturday, Wall Street Zen reports. How Royalty Pharma Prints Cash…
Pfizer: Buy Before The Street Catches Up To Its Own Numbers (NYSE:PFE)
Pfizer is rated buy, not for deep value, but due to a disconnect between management's bullish long-term growth guidance and a flat consensus earnings curve. Consensus models a permanent post-2026 revenue/EPS decline, but PFE's $13B product base is…
Caesars Taken Private By Fertitta Reaches Key Milestone, But Caution Is A Virtue (CZR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Akamai: Deal With Anthropic Boosts Existing AI-Driven Tailwind; Risks Cloud Horizon (AKAM)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Eli Lilly (NYSE: LLY), Novo Nordisk And Novartis Bet On Discovery Platforms Over Late-Stage Pipeline Assets
Big pharma's dealmaking appetite remains strong in 2026, but the strategic logic has shifted decisively toward platform access over outright company acquisitions. Eli Lilly & Co (NYSE: LLY) and China's InnoCare Pharma signed a research…
Nuclidium CEO: 'Our challenge remains the demonstration of clinical efficacy and utility'
Series CEO spotlight, Episode 19: Could Nuclidium become the Novartis of tomorrow? That is certainly the hope of the investors who have just injected more than CHF100 million into this promising Basel-based biotech start-up. Founded in 2021…
'I'm not JD Vance': the Appalachia memoir author running for Congress
Virginia's sixth congressional district has been in Republican hands for over 33 years, but Beth Macy, a longtime reporter with the Roanoke Times and author of Dopesick, a powerful account of the opioid crisis that swept through Appalachia two…
Best Growth Stocks To Research - September 26th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Jersey Mike's, Digital Turbine, and Pattern Group are the seven Growth stocks to watch today, according to MarketBeat's…
PMBI Recruitment: 178 Contractual Positions Available Across Various Departments
The Pharmaceuticals & Medical Devices Bureau of India (PMBI) is currently seeking applicants for 178 contractual roles across multiple departments, including Marketing, Quality, Logistics, and Media. Eligible candidates should possess degrees in…
Only governments can tame rapidly evolving AI models
The recent revelation that an OpenAI model hacked its way into the live systems of Hugging Face, and the resignation of Jacob Coxon, an Anthropic researcher who warned that ”the people building AI earnestly believe that it could kill us all…
Republicans see warning signs for Paxton in the Dallas-Fort Worth suburbs
Jill Tate has spent 30 years building and maintaining the Republican majority in Texas. In all that time, she's never been more worried about an election. “This is truly the first time I've felt in my bones we could lose the Texas House, and…
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Short Interest Jumps 183.4%
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totaling 360,790 shares, a growth of 183.4% from the August 31st…
Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to Sell
Tonix Pharmaceuticals (NASDAQ:TNXP - Get Free Report) was downgraded by Wall Street Zen from a 'hold' rating to a 'sell' rating in a research note issued on Saturday, Wall Street Zen reports. Pharma Frenzy: Volatility Ignites Biotech Sector A…
The Cholesterol Lie, the Cancer Cover-Up, and the Blue Zones That Prove It All Wrong
You've heard it a thousand times. Cholesterol is “public enemy number one.” Too much of it clogs your arteries, causes heart attacks, and kills you dead. Statins are the miracle drugs that save your life. Every doctor agrees. Every…
Receive a Daily briefing on Pharma Industry News
Get Started